NHS won’t get cutting-edge drugs unless it pays more, says AstraZeneca boss
Pascal Soriot says cost-effectiveness thresholds for new medicines have not changed for two decades Business live – latest updates The boss of AstraZeneca has said that unless the UK ramps up spending on new drugs, it could be on a trajectory to only being able to afford cheap, generic medicines (…)
Site référencé:
The Guardian (South&CentralAsia)
5413.jpg?width=140&quality=85&auto=format&fit=max&s=7e243059ae2ace21bbd25679f1a8e314, 5413.jpg?width=460&quality=85&auto=format&fit=max&s=698d170124b9c9a17f51cab99e3a6dc2, 5413.jpg?width=700&quality=85&auto=format&fit=max&s=57ad5df4e5c394a098bfc5a949ed579c
The Guardian (South&CentralAsia)
‘There is no money’ : As carbon markets collapse, what happens to the forests they promised to protect ?
6/11/2025
David Hockney : Some Very, Very, Very New Paintings Not Yet Shown in Paris - review : still innovating, still fascinating
6/11/2025
Jimi Famurewa’s recipe for Marmite and leek homity pie
6/11/2025
We published explosive stories about the president of El Salvador. Now we can’t go home
6/11/2025
The era of fine speeches and good intentions is over. Brazil’s Cop30 will be about action | Luiz Inácio Lula da Silva
6/11/2025
China-critical UK academics describe ‘extremely heavy’ pressure from Beijing
6/11/2025